Respiratory Medicine
-
Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial
This article has 12 authors:Reviewed by ScreenIT
-
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia
This article has 45 authors:Reviewed by ScreenIT
-
Effectiveness of Convalescent Plasma for Treatment of COVID-19 Patients
This article has 18 authors:Reviewed by ScreenIT
-
Survival and 30-days hospital outcome in hospitalized COVID-19 patients in Upper Egypt: Multi-center study
This article has 5 authors:Reviewed by ScreenIT
-
Risk factors for transfer from Respiratory Intermediate Care Unit to Intensive Care Unit in COVID-19
This article has 10 authors:Reviewed by ScreenIT
-
Development of a new aerosol barrier mask for mitigation of spread of SARS-CoV-2 and other infectious pathogens
This article has 8 authors:Reviewed by ScreenIT
-
Home-based and remote exercise testing in chronic respiratory disease, during the COVID-19 pandemic and beyond: a rapid review
This article has 12 authors:Reviewed by ScreenIT
-
Variation of SARS-CoV-2 viral loads by sample type, disease severity and time: a systematic review
This article has 8 authors:Reviewed by ScreenIT
-
Systematic review and meta-analysis of the prevalence of common respiratory viruses in children < 2 years with bronchiolitis in the pre-COVID-19 pandemic era
This article has 6 authors:Reviewed by ScreenIT
-
Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19
This article has 9 authors:Reviewed by ScreenIT